Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Wellcome Career Development Award For Sumana Sharma

Dr Sumana Sharma has won a Wellcome Career Development Award for her research investigating receptors in T cells.

Adam Wilkinson wins 2025 ISEH Janet Rowley Award

Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.

International Women's Day 2025

For International Women's Day on 8th March 2025, women from the MRC WIMM reflect on why this day is so important, the barriers and biases women can face in their careers, and which women have inspired them.

Rare Disease Day 2025

For Rare Disease Day on the 28th February, we spoke to three of our researchers about their work, discussing both the challenges and importance of researching and treating rare diseases.

Therapy Acceleration Lab granted UKAS accreditation

The Therapy Acceleration Lab (TAL) at the MRC WIMM was recently accredited by the United Kingdom Accreditation Service (UKAS) to the ISO 17025:2017 Standard as a testing laboratory, No. 28562.

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Innovation at the MRC WIMM

Here at the MRC Weatherall Institute of Molecular Medicine, we foster a strong culture of innovation.

Oxford Centre for Haematology Day 2025

The fourth Oxford Centre for Haematology Day, held at the MRC WIMM on 28th January 2025, was a very successful afternoon. Talks covered some of the breadth of haematology research in Oxford.

MRC WIMM researchers win 2024 RDM Graduate Prize

Congratulations to Charlotte Brierley and Patrick Pflughaupt, who were both awarded the 2024 RDM Graduate Prize after completing their PhDs at the MRC WIMM.

Green Action Week 2025 at the MRC WIMM

The University of Oxford’s Green Action Week takes place between the 10th and 14th February 2025 and there’s lots going on at the MRC WIMM!

Funding awarded for new theatre-based community engagement project

Alison Kay and Anne Goriely, together with Minna Jeffery (St. Anne’s College) and Lisa Hinton (Nuffield Dept. of Primary Care Health Sciences), have won an award from the University of Oxford’s PCER Fund for a project called “Making it personal”, which will use theatre to explore public perception of a new form of genetic testing.

MRC WIMM Festive Decorating Competition 2024

Teams across the MRC WIMM decorated their labs and offices with tinsel, handmade decorations and repurposed lab materials, filling the Institute with festive cheer.

Davis Group receives Wellcome Discovery Award

Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.

Vaccines, Meteorites and Gene Editing at IF Oxford 2024

In October, members of the MRC Weatherall Institute of Molecular Medicine took part in a series of events for Oxford Science + Ideas Festival.

35 Years of the MRC WIMM

In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.

New biomarker and therapeutic target identified for blood cancers

Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).

Professor Ahmed awarded funding to create world’s first ovarian cancer prevention vaccine

Researchers at the MRC WIMM have been awarded up to £600,000 from Cancer Research UK (CRUK) to create the world’s first vaccine to prevent ovarian cancer.

The Oxford Omics Data Camp 2024: Spatial Transcriptomics

The MRC WIMM Centre for Computational Biology recently hosted the inaugural Oxford Omics Data Camp at Jesus College. The camp featured cutting-edge discussions, hands-on workshops and a two-day hackathon.

Researchers develop new tool to better predict AML outcomes in older patients

In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.

Senior Fellowship awarded to Beth Psaila

Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.

Load More